Matches in SemOpenAlex for { <https://semopenalex.org/work/W3099309751> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W3099309751 endingPage "235" @default.
- W3099309751 startingPage "229" @default.
- W3099309751 abstract "La miastenia gravis ocular (MGo) es la forma de presentación de la enfermedad más frecuente. Un porcentaje variable de estos pacientes desarrollan una forma generalizada (MGg), siendo los factores de riesgo de conversión y el efecto protector del tratamiento inmunosupresor objeto de controversia en el momento actual. Diseñamos un estudio monocéntrico retrospectivo, con el objetivo de describir las características demográficas, clínicas y de laboratorio de una cohorte española de MGo, a partir de una serie de MG registrada en el Hospital Universitario de Albacete desde enero del 2008 hasta febrero de 2020. Seleccionamos 62 pacientes con MGo de una cohorte de 91 sujetos con MG (68,1%). La mediana de edad al diagnóstico fue de 68 (RIQ 52-75,3), con predominio de MGo de inicio muy tardío (n = 34, 54,8%) y de varones (n = 38, 61,3%). La diplopía binocular fue el síntoma inicial más frecuente (51,7%). La tasa de conversión a MGg fue del 50% (n = 31), con una mediana de tiempo de seis meses (RIQ 2-12,8). Encontramos asociación significativa entre ser mujer (OR: 5,46, IC 95% 1,16-25-74, p = 0,03) y tener AcAchR (OR: 8,86, IC 95% 1,15-68,41, p = 0,04), con el riesgo de desarrollar una MGg. La tasa de conversión de MGo en nuestra serie es relativamente elevada. La generalización tiene lugar principalmente durante los primeros dos años de evolución y está asociada al sexo femenino y, sobre todo, a la presencia de AcAchR. Ocular myasthenia gravis (MG) is the most common phenotype of MG at onset. A variable percentage of these patients develop secondary generalisation; the risk factors for conversion and the protective effect of immunosuppressive treatment are currently controversial. We designed a retrospective single-centre study with the aim of describing the demographic, clinical, and laboratory characteristics of a Spanish cohort of patients with ocular MG from Hospital Universitario de Albacete from January 2008 to February 2020. We selected 62 patients with ocular MG from a cohort of 91 patients with MG (68.1%). Median age at diagnosis was 68 (IQR, 52-75.3), and men accounted for 61.3% of the sample (n = 38). Most patients presented very late-onset ocular MG (n = 34, 54.8%). Binocular diplopia was the most frequent initial symptom (51.7%). The rate of progression to generalised MG was 50% (n = 31), with a median time of 6 months (IQR, 2-12.8). Female sex (OR: 5.46; 95% CI, 1.16-25-74; p = .03) and anti–acetylcholine receptor antibodies (OR: 8.86; 95% CI, 1.15-68.41; p = .04) were significantly associated with the risk of developing generalised MG. The conversion rate observed in our series is relatively high. Generalisation of MG mainly occurs during the first 2 years of progression, and is strongly associated with female sex and especially with the presence of anti–acetylcholine receptor antibodies." @default.
- W3099309751 created "2020-11-23" @default.
- W3099309751 creator A5002659783 @default.
- W3099309751 creator A5010786406 @default.
- W3099309751 creator A5013392819 @default.
- W3099309751 creator A5019888564 @default.
- W3099309751 creator A5038151978 @default.
- W3099309751 creator A5039959313 @default.
- W3099309751 creator A5059042129 @default.
- W3099309751 date "2023-05-01" @default.
- W3099309751 modified "2023-10-01" @default.
- W3099309751 title "Miastenia gravis ocular y factores asociados al desarrollo de una generalización secundaria: descripción de una serie española" @default.
- W3099309751 cites W1661216026 @default.
- W3099309751 cites W2015385567 @default.
- W3099309751 cites W2028108956 @default.
- W3099309751 cites W2035289940 @default.
- W3099309751 cites W2041684666 @default.
- W3099309751 cites W2053680723 @default.
- W3099309751 cites W2069768552 @default.
- W3099309751 cites W2072475795 @default.
- W3099309751 cites W2078966021 @default.
- W3099309751 cites W2089117937 @default.
- W3099309751 cites W2119417201 @default.
- W3099309751 cites W2158122370 @default.
- W3099309751 cites W2285766749 @default.
- W3099309751 cites W2312452396 @default.
- W3099309751 cites W2461303519 @default.
- W3099309751 cites W2607192280 @default.
- W3099309751 cites W2659815784 @default.
- W3099309751 cites W2735026826 @default.
- W3099309751 cites W2755762791 @default.
- W3099309751 cites W2761621565 @default.
- W3099309751 cites W2787901111 @default.
- W3099309751 cites W2793756090 @default.
- W3099309751 cites W2806187231 @default.
- W3099309751 cites W2891865821 @default.
- W3099309751 cites W2913761737 @default.
- W3099309751 cites W2975901834 @default.
- W3099309751 cites W2990454636 @default.
- W3099309751 cites W3008214101 @default.
- W3099309751 cites W992550965 @default.
- W3099309751 doi "https://doi.org/10.1016/j.nrl.2020.09.004" @default.
- W3099309751 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33208236" @default.
- W3099309751 hasPublicationYear "2023" @default.
- W3099309751 type Work @default.
- W3099309751 sameAs 3099309751 @default.
- W3099309751 citedByCount "0" @default.
- W3099309751 crossrefType "journal-article" @default.
- W3099309751 hasAuthorship W3099309751A5002659783 @default.
- W3099309751 hasAuthorship W3099309751A5010786406 @default.
- W3099309751 hasAuthorship W3099309751A5013392819 @default.
- W3099309751 hasAuthorship W3099309751A5019888564 @default.
- W3099309751 hasAuthorship W3099309751A5038151978 @default.
- W3099309751 hasAuthorship W3099309751A5039959313 @default.
- W3099309751 hasAuthorship W3099309751A5059042129 @default.
- W3099309751 hasBestOaLocation W30993097511 @default.
- W3099309751 hasConcept C29456083 @default.
- W3099309751 hasConcept C71924100 @default.
- W3099309751 hasConceptScore W3099309751C29456083 @default.
- W3099309751 hasConceptScore W3099309751C71924100 @default.
- W3099309751 hasIssue "4" @default.
- W3099309751 hasLocation W30993097511 @default.
- W3099309751 hasOpenAccess W3099309751 @default.
- W3099309751 hasPrimaryLocation W30993097511 @default.
- W3099309751 hasRelatedWork W1506200166 @default.
- W3099309751 hasRelatedWork W1995515455 @default.
- W3099309751 hasRelatedWork W2048182022 @default.
- W3099309751 hasRelatedWork W2080531066 @default.
- W3099309751 hasRelatedWork W2604872355 @default.
- W3099309751 hasRelatedWork W2748952813 @default.
- W3099309751 hasRelatedWork W2899084033 @default.
- W3099309751 hasRelatedWork W3031052312 @default.
- W3099309751 hasRelatedWork W3032375762 @default.
- W3099309751 hasRelatedWork W3108674512 @default.
- W3099309751 hasVolume "38" @default.
- W3099309751 isParatext "false" @default.
- W3099309751 isRetracted "false" @default.
- W3099309751 magId "3099309751" @default.
- W3099309751 workType "article" @default.